Hearing Aid and Individuals With Cognitive Disorders

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

December 1, 2019

Primary Completion Date

November 7, 2024

Study Completion Date

November 7, 2024

Conditions
Presbycusis, BilateralAlzheimer Disease 2 Due to Apoe4 IsoformMild Cognitive Impairment
Interventions
DEVICE

Audiologist-based fitting

Hearing aids will be fitted by audiologists using established procedures.

DEVICE

Service-only Fitting

This intervention group is designed to explore the contribution of amplification devices in hearing aid intervention, which consists of devices and services. In this intervention group, audiological services plus hearing aids that provide minimum amplification will be provided. Specifically, patient participants in this group will receive audiological services (e.g., counselling and education), except that the hearing aids will be set to provide no amplification other than what is needed to overcome any sounds that are dampened by the earpieces.

DEVICE

Device-only fitting

This intervention group is designed to explore the contribution of amplification devices in hearing aid intervention, which consists of devices and services. The patient participants in this intervention group will have minimum services regarding the pre-fitting, selection, and orientation of the hearing aids. The participants will have a hearing evaluation, including pure-tone audiometry. The audiologist will select the amplification characteristics and non-custom ear piece based on the audiogram. The audiologist will then briefly orient the participant on how to use the hearing aids and counsel on how to optimize their performance.

Trial Locations (2)

37232

Vanderbilt University Medical Center, Nashville

52242

University of Iowa, Iowa City

All Listed Sponsors
collaborator

Vanderbilt University Medical Center

OTHER

collaborator

National Institute on Deafness and Other Communication Disorders (NIDCD)

NIH

lead

Yu-Hsiang Wu

OTHER

NCT04049643 - Hearing Aid and Individuals With Cognitive Disorders | Biotech Hunter | Biotech Hunter